Predictors of Functional Impairment in Severe COVID-19 Patients Two Months After Discharge
- PMID: 39713096
- PMCID: PMC11660074
- DOI: 10.1177/29768675241305102
Predictors of Functional Impairment in Severe COVID-19 Patients Two Months After Discharge
Abstract
Background: The Post-COVID-19 Functional Status (PCFS) scale is a validated tool used to measure the functional status of patients discharged from the hospital.
Objectives: To describe the functional limitations of hospitalized COVID-19 patients at the time of discharge and two months afterward, and to identify risk factors associated with functional impairment.
Design: Retrospective study.
Methods: A total of 540 patients were included in this monocentric study. The functional status assessment using the PCFS scale and ventilatory needs were recorded at discharge and two months later. Univariate and multivariate analyses were performed in order to identify the risk factors of a high PCFS score.
Results: Two months after discharge, the PCFS grade was 0 in 60,6% of the survivors, 1 in 24.5%, 2 in 6.9%, 3 in 2.8%, and 4 in 5.3%. The identified risk factors of a high PCFS scale were: age, arterial hypertension, diabetes mellitus, immunosuppression, cardiovascular disease, high need for oxygen and high News2 score at admission, a high percentage of ground glass at chest CT scan performed at admission or during follow-up, elevated leukocytes, neutrophils, LDH, D-dimers, procalcitonin, and serum creatinine levels. During the hospital stay, treatment with steroids, tocilizumab, longer duration of hospitalization, ICU admission and prolonged stay, and the occurrence of thromboembolic or hemorrhagic events were also significantly associated with a higher PCFS. Multivariate analysis identified that only age and a high News2 score at admission were independent risk factors of a low PCFS score.
Conclusion: Multiple risk factors for a higher PCFS score were identified, but only age and a high News2 score at admission were found to be independent risk factors.
Keywords: PCFS scale; Post-COVID-19; functional limitations.
Plain language summary
Study aiming to identify the risk factors for functional impairment in patients recovering from Severe COVID-19 infection.
Why was the study done?: COVID-19 survivors can experience persistent symptoms during the recovery phase, affecting their physical, cognitive, or mental health and limiting their ability to engage in regular physical activities. The study aims to identify the factors that best predict the functional impairment in these patients.
What did the researchers do?: The study included 540 patients. Their functional status was assessed at discharge and again two months later using a specific scale. Statistical analyses were conducted to identify the risk factors for functional impairment.
What did the researchers find?: Two months after hospitalization for COVID-19, 4 out of 10 patients still exhibited mild to severe functional impairment. The study identified several risk factors, with age and the severity of COVID-19 infection emerging as the most significant predictors of functional impairment after severe COVID-19.
What do the findings mean?: Clinicians and physicians taking care of COVID-19 hospitalized patients can use the identified risk factors to predict early on which patients may require rehabilitation or home help following their recovery.
© The Author(s) 2024.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Relationship between functional status and fatigue after COVID-19 infection: a multicenter study from Türkiye.Turk J Med Sci. 2024 Jul 14;54(4):623-630. doi: 10.55730/1300-0144.5831. eCollection 2024. Turk J Med Sci. 2024. PMID: 39295597 Free PMC article.
-
Post-COVID-19 Intensive Care Unit-Acquired Weakness Compromises Long-Term Functional Status.Phys Ther. 2023 Dec 6;103(12):pzad117. doi: 10.1093/ptj/pzad117. Phys Ther. 2023. PMID: 37658771
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
-
Liberation from prolonged mechanical ventilation.Crit Care Clin. 2002 Jul;18(3):569-95. doi: 10.1016/s0749-0704(02)00016-7. Crit Care Clin. 2002. PMID: 12140914 Review.
References
LinkOut - more resources
Full Text Sources